Related Experiment Video
Updated: Aug 5, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Higher-order assembly of a type IX retron enables exploitation for designer antimicrobials
Grace Nicole Hibshman1,2, Linhan Wang3, Nicole MacRae1,4
1California Institute for Quantitative Biosciences and Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Abstract:
Bacterial defense systems provide a rich reservoir for biotechnological innovation. Retrons are tripartite abortive infection systems that detect phage invasion using reverse-transcribed DNA (msDNA), but how they structurally couple threat detection to effector activation remains poorly understood. Here, we determine the cryo-EM structure and activation mechanism of retron-Kva2, a type IX retron from the human pathogen Klebsiella variicola. We reveal that retron-Kva2 assembles into an asymmetric, higher-order ribonucleoprotein complex that sequesters a toxic dimeric HEPN RNase at its core. We identify a natural phage trigger as the phage T5 protein D5, which activates the retron through structural mimicry. Mirroring the retron-Kva2 winged-helix protein, the helix-turn-helix fold of D5 binds the msDNA sensor, driving conformational remodeling that unleashes HEPN-mediated tRNA cleavage and growth arrest. Because retron-Kva2 surveils a structural fold via msDNA binding, rather than a primary sequence, this recognition mechanism provides a broadly exploitable pathway for programmable activation. Harnessing this structure-based logic, we computationally designed de novo synthetic triggers that activate retron-Kva2-mediated bacterial growth arrest in vivo. Our findings reveal the architectural basis of type IX retron immunity and establish a structure-guided paradigm for repurposing bacterial defense systems into precision-honed antimicrobial therapeutics.
Related Concept Videos
Production of Antibiotics
Antibiotic Selection
Production of Pharmaceuticals
Inhibitors of Gram-positive Cell Wall Synthesis
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...

